Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,343.73 -43.85 -0.28%
S&P 500 1,668.40 -0.76 -0.05%
NASDAQ 3,471.79 -30.33 -0.87%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 13.36 0.47%
FTSE 100 6,840.27 36.40 0.53%
DAX 8,530.89 58.69 0.69%
Ticker Volume Price Price Delta
NIKKEI 15,627.26 246.24 1.60%
TOPIX 1,276.03 5.64 0.44%
HANG SENG 23,261.08 -105.29 -0.45%

GenOn Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale of GenOn Energy, Inc. to NRG Energy, Inc.



  GenOn Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP
  Investigate Sale of GenOn Energy, Inc. to NRG Energy, Inc.

Business Wire

DALLAS -- August 01, 2012

Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers Taylor, LLP are
investigating the sale of GenOn Energy, Inc. (“GenOn” or “GEN”) (NYSE: GEN) to
NRG Energy, Inc. for shareholders. Under the proposed transaction, GenOn
shareholders will receive 0.1216 of a share of NRG common stock for each share
of GenOn stock owned. Based upon NRG’s closing price on July 20th, GenOn
shareholders will only receive a value of approximately $2.19 per GenOn share,
well below at least one analyst’s estimate of $4.50 per share.

If you are an affected investor, and you want to learn more about the lawsuit
or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free
(877) 728-9607, via e-mail at patrick@powerstaylor.com, or Willie Briscoe at
The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at
WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.

The proposed transaction is an all-stock deal valued at approximately $1.7
billion.

The investigation centers on whether GenOn shareholders are receiving adequate
compensation for their shares in the buyout, whether the transaction
undervalues GenOn stock, and whether GenOn’s board attempted to obtain the
highest share price for all shareholders prior to agreeing to the deal.
Notably, according to at least one analyst with Yahoo! Finance, the true
inherent value of GenOn could be as high as $4.50 per share. “Due to the lack
of a significant premium to the shareholders and other factors, we believe
that the transaction may undervalue GEN stock. Our lawsuit will seek to obtain
the highest share price for all shareholders,” said shareholder rights
attorney Willie Briscoe.

The Briscoe Law Firm, PLLC is a full service business litigation and
shareholder rights advocacy firm with more than 20 years of experience in
complex litigation and transactional matters.

Powers Taylor, LLP is a boutique litigation law firm that handles a variety of
complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits, and
security class actions.

Contact:

Powers Taylor, LLP
Patrick Powers, 877-728-9607
patrick@powerstaylor.com
or
The Briscoe Law Firm, PLLC
Willie Briscoe, 214-706-9314
WBriscoe@TheBriscoeLawFirm.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement